Baker Bros. Advisors LP Kiniksa Pharmaceuticals, Ltd. Transaction History

Baker Bros. Advisors LP

  • $7.52 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$10.44 - $16.48 $104,400 - $164,800
10,000 Added 0.36%
2,809,577 $39.6 Million
Q2 2019

Aug 14, 2019
SELL
$13.2 - $20.39 $2.65 Million - $4.09 Million
-200,423 Reduced 6.68%
2,799,577 $37.9 Million
Q2 2018

Aug 14, 2018
BUY
$16.73 - $20.35 $50.2 Million - $61.1 Million
3,000,000 New
3,000,000 $52.1 Million

Others Institutions Holding KNSA

# of Institutions
11
Shares Held
1.89M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $859M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Baker Bros. Advisors LP Portfolio

Follow Baker Bros. Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Bros. Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email